Therapeutic agent elution control process

Details Therapeutic agent elution control process Therapeutic agent elution control process

A - Human Necessities

61

L

A61L 31/16 (2006.01) A61L 31/10 (2006.01) B05D 1/02 (2006.01) B05D 1/18 (2006.01) A61K 31/436 (2006.01)

Patent

CA 2594906

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including vulnerable plaque. Implantable coated medical devices may be processed through annealing to better control the elution characteristics of the therapeutic agents. Furthermore, annealing leads to better therapeutic agent stability and a larger device shelf-life.

Affiliated with

Also associated with

Rating

Therapeutic agent elution control process does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent elution control process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent elution control process will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1853107